STI Screening and Treatment in Women
Risk Assessment and Screening Recommendations
- The American College of Obstetricians and Gynecologists recommends that all sexually active women under 25 years receive annual screening for chlamydia, gonorrhea, HIV, and syphilis, with testing performed using nucleic acid amplification tests (NAATs) from cervical or vaginal specimens 1
- A structured sexual history using the "Five P's" framework (partners, practices, prevention of pregnancy, protection from STIs, and past history of STIs) should be conducted to identify HIV and viral hepatitis risk 2
- Women 25 years and older with risk factors, such as new or multiple sex partners, should be screened annually for chlamydia, gonorrhea, HIV, and syphilis 1
Diagnostic Testing Methods
- NAATs are the preferred method for diagnosing chlamydia and gonorrhea, with sensitivities of 86.1%-100% and specificities of 97.1%-100% 4
- The Centers for Disease Control and Prevention recommends that pregnant women be screened for syphilis at the first prenatal visit, third trimester, and delivery 3
Treatment Recommendations
- The Centers for Disease Control and Prevention recommends that women with cervicitis receive presumptive treatment with azithromycin 1 g orally single dose or doxycycline 100 mg orally twice daily for 7 days before test results are available, especially in high-prevalence settings (>5% gonorrhea prevalence) 4
- Pregnant women with chlamydia or gonorrhea should be treated with azithromycin or amoxicillin 4
Partner Management and Follow-Up
- All sex partners from the past 60 days should be notified, examined, and treated for the same STDs as the index patient 1
- Patients and partners must abstain from sexual intercourse for 7 days after single-dose therapy or until completion of 7-day regimen 4
- Retest 3 months after treatment for chlamydia or gonorrhea to detect reinfection 1